COMMUNIQUÉS West-GlobeNewswire

Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody
10/08/2026
BOSTON, Aug. 09, 2026 (GLOBE NEWSWIRE) -- Kyungdong Pharmaceutical announced that it has successfully completed a cell line development campaign for a biosimilar antibody candidate, in collaboration with Asimov, the [...]
AVITA Medical to Host Investor Webinar Briefing
10/08/2026
VALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective [...]
RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
09/08/2026
Total Company Revenue increased 25.0% to a quarterly record of $622.7 million in the second quarter of 2026 from $498.2 million in the second quarter of 2025 Revenue from the Digital Health reportable segment (inclusive [...]
Actually Sleeping Surpasses 211 Families Served With Personalized Baby and Toddler Sleep Coaching
09/08/2026
Founder Dr. Samantha Abramson pairs a pharmacy background with real-time sleep tracking and one-on-one coaching to help parents build routines that work for their household United States, Aug. 09, 2026 (GLOBE NEWSWIRE [...]
Tyros Biopharma Accelerates Expansion of Women’s Health Portfolio With Four New Product Introductions in 2026
08/08/2026
Montreal, QC, Aug. 08, 2026 (GLOBE NEWSWIRE) -- Tyros Biopharma, a privately held Canadian pharmaceutical company focused on women’s health, is pleased to announce its continued growth following the addition of four new [...]
Life Peptides Launches Company-Wide Transparency Initiative to Advance Research Peptide Quality and Buyer Education
08/08/2026
Cheyenne, Wyoming, Aug. 08, 2026 (GLOBE NEWSWIRE) -- Life Peptides , a trusted supplier of high-purity laboratory research peptides, announces the launch of a company-wide transparency initiative designed to help [...]
Magnendo Awarded Up to $32M by ARPA-H to Advance Autonomous Robotic Stroke Intervention
08/08/2026
Federal award supports development of magnetic robotic navigation technology designed to overcome the physical barriers limiting endovascular navigation and pave the way for autonomous endovascular interventions NEWTON [...]
Nova Leap Health Corp. Posts Record Q2 2026 Revenue, Income from Operating Activities and Adjusted EBITDA
07/08/2026
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 07, 2026 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
SodaTide Capsule Label Guide: What the Supplement Facts Panel, Serving Directions, and Safety Statements Disclose for 2026
07/08/2026
SodaTide's 211 mg Chicory Root Inulin, 100 mg Potato Resistant Starch, 36 mg Probiotic Blend, and Refrigeration Requirements Explained Largo, FL, Aug. 07, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07/08/2026
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
07/08/2026
WOBURN, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/08/2026
BEDFORD, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
07/08/2026
SAN FRANCISCO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other [...]
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/08/2026
BRISBANE, Calif., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on August 3, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera [...]
Amwell makes grant to new employees under inducement plan
07/08/2026
BOSTON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announces that on August 7, Amwell made grants of [...]
Spyre Therapeutics Announces Grants of Inducement Awards
07/08/2026
WALTHAM, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate [...]
Entera Announces Second Quarter 2026 Financial Results and Business Updates
07/08/2026
U.S. Food and Drug Administration (FDA) Alignment on 12-Month Registrational Phase 3 Study to Support NDA for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis [...]
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
07/08/2026
Conference Call 8:30 a.m. ET, Monday, August 10, 2026 MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company [...]
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
07/08/2026
LONDON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Canaccord Genuity 46 th Annual Growth [...]

Pages